Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

Cystic fibrosis (CF) is an autosomal ... and bronchiectasis with resulting marked decline in pulmonary function. The only treatment for end-stage CF lung disease is lung transplantation.

This was supported by comparing their molecular characteristics to samples from patients who had end-stage pulmonary fibrosis ...

PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging ... of the experiences of people with end-stage interstitial lung disease and their family ...

Idiopathic pulmonary fibrosis (IPF ... membrane oxygenation as a bridge to transplant has enabled more end-stage patients to survive to transplant. The number of transplantable organs is also ...

The effort by the Center for Regenerative Medicine of Boston University, Boston Medical Center, and GSK aims to find new ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Boehringer Ingelheim is seeking regulatory approval for nerandomilast after a Phase III trial in idiopathic pulmonary ...

Lung transplantation stands as a critical option for patients suffering from end-stage diseases such as chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, and cystic fibrosis ...

Met primary objective demonstrating nintedanib DPI was safe and well toleratedParticipants did not experience adverse events typically reported ...

TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF ...

Dyspnea is often a clinical feature of progressive CF lung disease and is more prevalent during pulmonary exacerbations ... in an adolescent patient with end-stage CF who experienced acute ...